Shuttle Pharmaceuticals Holdings (SHPH) Total Liabilities (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Total Liabilities history runs 6 years deep, the most recent figure standing at $8.5 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 317.95% year-over-year to $8.5 million in Q1 2026; TTM through Mar 2026 was $8.5 million, a 317.95% increase from a year earlier, with the FY2025 full-year figure at $8.2 million, up 357.48% from the prior year.
• Total Liabilities climbed to $8.5 million in Q1 2026 per SHPH's latest filing, from $8.2 million in the prior quarter.
• Across five years, Total Liabilities topped out at $8.5 million in Q1 2026 and bottomed at $975676.0 in Q4 2022.
• The 5-year median for Total Liabilities is $2.0 million (2024), against an average of $2.8 million.
• Across the five-year window, Total Liabilities sank 57.2% in 2022 and soared 357.48% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $975676.0 in 2022, then jumped by 94.32% to $1.9 million in 2023, then decreased by 5.21% to $1.8 million in 2024, then surged by 357.48% to $8.2 million in 2025, then rose by 2.94% to $8.5 million in 2026.
• Per Business Quant, the three latest SHPH Total Liabilities figures stand at $8.5 million (Q1 2026), $8.2 million (Q4 2025), and $2.1 million (Q3 2025).